Client Alert
Pharmig code of conduct amended
The Association of the Austrian Pharmaceutical Industry has amended the PHARMIG Code of Conduct, effective as of 1 July 2020.
All PHARMIG members (currently more than 100 companies) must comply with the code. The new changes include a new prohibition on product branding, a ban on undue benefits for representatives of healthcare or patient organisations, restrictions regarding claims which are not sufficiently supported by scientific evidence, and more.
To learn more, please open the attached file.
Read the full text
Read the full text
